Becoming an IRB Member

Are you interested in becoming a member of the Central DOE IRB (CDOEIRB)? If so, please contact the DOE Human Subjects Protection Program through our Contact page.

Highlights

View all Highlights

The final version of the redesigned drug binds tightly to the main COVID-19 protease, an enzyme the virus needs to multiply. The drug’s structure is effective even against mutated forms that resist other treatments.

Redesigned Hepatitis C Drug Becomes a Powerful New Treatment for COVID-19

Scientists transformed an old drug into a potent COVID-19 treatment effective against drug-resistant variants.

Researchers tested multiple distillable amine-based solvents to see how they performed in pretreatment processes for biomass. They found butylamine was a superior solvent.

A Standout Solvent for Today’s Biorefineries

Researchers identify butylamine as a promising solution to many challenges at biorefineries.

Contact Human Subjects Protection Program

Address U.S. Department of Energy
SC-23/Germantown Building
1000 Independence Ave., SW
Washington, DC 20585